|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
|
|---|---|---|---|
| REVENUE | |||
| Revenue - third party | |||
| Revenue - related party | |||
| Revenue | |||
| Third party | |||
| Related Party | |||
| Total revenue | |||
| COST OF REVENUE AND RELATED TAX | |||
| Cost of revenue | |||
| Business and sales related tax | |||
| Total cost of revenue and related tax | |||
| GROSS PROFIT | |||
| OPERATING EXPENSES | |||
| Selling expenses | |||
| General and administrative expenses | |||
| Research and development expenses | |||
| Total operating expenses | |||
| INCOME FROM OPERATIONS | |||
| Interest income (expense), net | |||
| OTHER INCOME | |||
| Interest income, net | |||
| Foreign exchange gain (loss) | |||
| Other income, net | |||
| Total other income, net | |||
| INCOME BEFORE INCOME TAX PROVISION | |||
| PROVISION FOR INCOME TAXES | |||
| NET INCOME | |||
| Foreign currency translation (loss) gain | |||
| Comprehensive income | |||
| Less: comprehensive income (loss) attributable to non-controlling interest | |||
| COMPREHENSIVE INCOME ATTRIBUTABLE TO JIN MEDICAL INTERNATIONAL LTD. | |||
| Earnings per Ordinary Share - basic (in Dollars per share) | |||
| Earnings per Ordinary Share - diluted (in Dollars per share) | |||
| Weighted average shares - basic (in Shares) | |||
| Weighted average shares - diluted (in Shares) | |||
| Less: net income (loss) attributable to non-controlling interest | |||
| NET INCOME ATTRIBUTABLE TO JIN MEDICAL INTERNATIONAL LTD. |
Loading...
